NextCure Inc
PublicNextCure Inc is now publicly traded
The data on this page reflects NextCure Inc's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Series A
Mar 5, 2026
Total Funding Raised
$19M
Company Overview
NextCure Inc is a biotechnology company that discovers and develops novel immunomedicines to treat cancer and other immune-related diseases.
Sector
Healthcare
AI Layer
Non-AI
Keywords
antibody-drug conjugatesADCsimmuno-oncologyclinical-stage biopharmadrug discovery platformtreatment resistant cancernovel target identificationsolid tumorsmonoclonal antibodybiopharma partnershipstumor microenvironmentfusion proteinAcute Myeloid LeukemiaAML
NextCure Inc Comparables
Compare NextCure Inc with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OnCusp Therapeutics | 82% | |
| Immunitas Therapeutics | 76% | |
| NextPoint Therapeutics | 71% |
NextCure Inc Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 5, 2026 |
NextCure Inc Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Series A |
| Oncology Ventures | Series A |
| Cencora Ventures | Series A |
NextCure Inc Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFirmographic Details
HeadquartersUnited States
Employee Range49
Year Founded2015
Last FundingMar 5, 2026
See something wrong or outdated?